Safety and Efficacy of AM712 in Patients with NAMD

Clinical trial NCT05345769 · COMPLETED

Trial details

NCT number: NCT05345769
Sponsor: AffaMed Therapeutics Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2022-04-28
Primary completion: 2024-11-04
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.